abm human recombinant protein
Recombinant Human CXCL11 | Z100585
- SKU:
- Z100585
- Availability:
- 5 to 7 Days Shipment
Description
abm | Recombinant Human CXCL11 | Z100585
The CXCL11 belongs to the CXC chemokine family characterized by the presence of one amino acid in between the two NH2-terminal cysteines. CXCL11 is produced by a variety of cells including leukocytes, fibroblasts, and endothelial cells upon stimulation with interferons (IFNs). Simultaneous stimulation of fibroblasts or endothelial cells with IFN-gamma and Interleukin-1b or the TLR3 ligand double-stranded RNA results in a synergistic increase of CXCL11 production. CXCL11 attracts natural killer cells and activated T-helper 1 cells. Like CXCL9 and CXCL10, CXCL11 signals through CXC chemokine receptor 3 (CXCR3).
Functions:
Determined by its ability to chemoattract human T cells using a concentration range of 2.0-10.0 ng/mL
Organism:
Human
Source:
E. coli
Alias:
CXCL11, C-X-C motif chemokine 11, Beta-R1, H174, Interferon gamma-inducible protein 9, IP-9, Interferon-inducible T-cell alpha chemoattractant, I-TAC, Small-inducible cytokine B11
Recombinant Human IFN-Inducible T-cell Chemoattractant (CXCL11)
Gene Symbol:
CXCL11
Gene ID:
6373
Accession:
O14625
Formulation:
Lyophilized from a 0.2 μm filtered solution in PB,100 mM NaCl pH 7.5
Solubility:
A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Appearance:
Lyophilized Powder
Molecular Weight (kDa):
8
Molecular Weight 2 (kDA):
N/A
Molecular Weight 3 (kDA):
N/A
Purity:
>95% as determined by SDS-PAGE
Concentration:
<1.0 EU/μg of recombinant protein as determined by the LAL method
Shipping Condition :
Ambient Temperature
Storage Condition:
The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.